Invention Grant
- Patent Title: Inhibitors of RAF kinases
-
Application No.: US17498530Application Date: 2021-10-11
-
Publication No.: US11377431B2Publication Date: 2022-07-05
- Inventor: Stephen W. Kaldor , Toufike Kanouni , Eric Murphy , Jason Cox , Robert Kania
- Applicant: Kinnate Biopharma Inc.
- Applicant Address: US CA San Diego
- Assignee: Kinnate Biopharma Inc.
- Current Assignee: Kinnate Biopharma Inc.
- Current Assignee Address: US CA San Diego
- Agency: Wilson Sonsini Goodrich & Rosati
- Main IPC: C07D295/155
- IPC: C07D295/155 ; C07D405/12 ; C07D401/12
Abstract:
Provided herein are inhibitors of receptor tyrosine kinase effector, RAF, pharmaceutical compositions comprising said compounds, and methods for using said compounds for the treatment of diseases.
Public/Granted literature
- US20220112170A1 INHIBITORS OF RAF KINASES Public/Granted day:2022-04-14
Information query
